Skip to content
THURSDAY, NOVEMBER 19, 2026

Independently reported.

Health

Will the US lose its measles elimination status? What PAHO is deciding this week

A closed-door commission meets through November 13 and the result is due early next week. The test is genetic, not a case count: did one virus lineage spread for 12 months straight?

By Rosa Delgado, Courts, Law & Health Policy

· 5 min read

Empty pediatric exam room in morning light with a tray of unlabeled vaccine vials and a syringe on the counter.
Illustration: Trestlewire

The essentials

  • •PAHO's Regional Verification Commission meets in Washington through November 13, and Director Jarbas Barbosa makes the final call, with the result expected early next week.
  • •The test is whether the same measles genotype and lineage circulated for 12 months or more, counting from January 20, 2025.
  • •The CDC reports 5,182 confirmed cases in 2026 as of November 5, and 96 percent are linked to outbreaks.
  • •Noel Brewer, who chairs an independent US measles advisory panel, says the Arizona-Utah outbreak that began in June 2025 likely meets the 12-month test.
  • •The CDC director says the agency's response stays the same whatever PAHO decides.

No decision has been made yet. A panel of outside experts is meeting in Washington through November 13 to decide whether the United States, which has been officially free of endemic measles since 2000, still deserves that label. The Pan American Health Organization says its director, Jarbas Barbosa, will make the call and that the result is expected to be public early next week, according to Reuters.

What exactly is the commission deciding?

Not whether the country has a lot of measles. It does. The question is narrower and genetic: has the same virus genotype and lineage circulated without a break for 12 months or more? PAHO defines that as re-established endemic transmission, and in a March 2 notice it set the US clock to start on January 20, 2025, the onset of the reported outbreaks.

The panel is PAHO's Regional Verification Commission, an independent technical body that reports to the director. It hears from every country in the Americas each year. It recommends, and Barbosa classifies. PAHO moved the US review from April to this November meeting, and said part of the reason was that US health authorities were still running full viral genome sequencing on the outbreaks.

What does the evidence look like?

The CDC's measles page, updated November 6, lists 5,182 confirmed US cases in 2026 as of November 5. That is more than double the roughly 2,300 counted in all of 2025. The agency reports 43 new outbreaks this year, and 4,993 of the cases (96 percent) are tied to an outbreak rather than to a single imported infection.

96%

of 2026 US measles cases linked to an outbreak

4,993 of 5,182 confirmed cases as of November 5, per the CDC

A KFF policy brief by Josh Michaud sets the benchmark. When US experts re-verified elimination in 2011, they looked at 2001 to 2011: 64 outbreaks in ten years, a median outbreak of six cases, and about 40 percent of cases imported. In 2025 alone the country had 48 outbreaks, and KFF put the imported share at about 10 percent.

Noel Brewer, a public health professor at the University of North Carolina who chairs an independent US advisory panel on measles, presented the CDC's status report to the commission on Tuesday. He would not give details. He did say that, based on public data, the Arizona-Utah outbreak, which began in June 2025 and is still going, likely meets the 12-month test.

What does a loss look like on paper?

There is a recent template. Canada lost its status in November 2025 after the commission concluded the virus had circulated there for at least 12 months. Because regional status depends on every member, the Americas as a whole lost their measles-free standing that day. Reuters reports that Spain and the UK have since lost theirs too, after reviews by World Health Organization experts. The US left the WHO but remains a PAHO member, so this review still reaches it.

The US was not in the clear going in. At the November 2025 meeting the commission placed it in a category called "sustained with major concerns," KFF reports. Mexico and Bolivia are also on this year's watch list because of prolonged outbreaks, a PAHO spokesperson told Reuters.

Why did it come to this?

The measles virus needs about 95 percent of a population to be immune before outbreaks stop spreading. Kindergarten MMR coverage nationally fell from 95.2 percent in 2019-2020 to 92.5 percent in 2024-2025, KFF reports, and more than three quarters of states were below the 95 percent target. Coverage ranged from 78.5 percent in Idaho to 98.2 percent in Connecticut.

The politics are in the reporting too. Reuters notes that Health Secretary Robert F. Kennedy Jr. has spread doubts about measles vaccine safety without scientific evidence, and that experts blame his moves to reduce childhood immunizations for adding to hesitancy. The Department of Health and Human Services responded that national vaccination rates were already falling before he took office.

What changes if the answer is yes?

Less than the headline suggests, at least for now. Dr. Erica Schwartz, the CDC director, said this week that if the US loses the status, "we're going to be doing the same exact thing that we've been doing today," starting with the message that the MMR vaccine is the number one way to prevent measles. In the sources reviewed for this piece, PAHO describes a classification communicated to national authorities, not a penalty.

Brewer made the same point from the other side. Win or lose, he said, "we have a huge problem with measles." Demetre Daskalakis, a former top CDC official who resigned after Kennedy took office, called the status a measure of public health capacity: "Measles is the great indicator of where the cracks are in our foundation."

One count to watch is deaths. The CDC page lists four and marks the figure as subject to change. Reuters, tallying state and federal reports since early 2025, reports nearly 7,500 cases and 11 deaths. The two numbers cover different periods and counting methods, and the gap has not been explained by either agency in the sources reviewed.

The next date is early next week, when PAHO is expected to announce the classification. A yes would put the country in the same column as Canada, and a no would leave it with a measles total that the CDC's own page shows is still climbing.

Frequently Asked Questions

When will PAHO announce the US measles decision?
The commission meets through November 13 in Washington. A PAHO spokesperson told Reuters the determination is expected to be public early next week.
Has the US already lost measles elimination status?
Not yet. No classification has been announced as of November 11, 2026. Director Jarbas Barbosa makes the final decision after the commission's recommendation.
What is the test for losing the status?
PAHO asks whether the same virus genotype and lineage circulated without interruption for 12 months or more. For the US, the analysis period starts January 20, 2025.
  • measles
  • PAHO
  • measles elimination
  • CDC
  • MMR vaccine
  • Canada

Sources

  1. 01Update on the review of measles elimination status, Pan American Health Organizationpaho.org
  2. 02US faces loss of measles-free status as experts meet for review, Reuters1027wbow.com
  3. 03Measles Elimination Status: What It Is and How the U.S. Could Lose It, KFFkff.org
  4. 04Measles cases and outbreaks, Centers for Disease Control and Preventioncdc.gov
  5. 05US measles cases reach 5,182 as PAHO weighs elimination status, NationofChangenationofchange.org

Corrections

No corrections have been made to this article.

About the reporter

Rosa Delgado

Legal Affairs Reporter, Trestlewire

I went to law school intending to practice, passed the bar, and then took a job covering the courts for a newspaper in San Antonio in 2002. I never looked back. Courts are where policy arguments finally have to stand up on their own, without the press conference around them.

Read full bio and all stories →

The Morning Wire

The day’s reporting, in your inbox before nine.

Free. Unsubscribe any time. We never share your address.